Hemogenyx conclui transferência de tecnologia para terapia CAR-T para CDMO – br.investing.com

<p><a href&equals;"https&colon;&sol;&sol;news&period;google&period;com&sol;rss&sol;articles&sol;CBMiyAFBVV95cUxOSDBwZ1dpVnI4eXpiTF8yUlkzLUdISnBnQ0JQTlZaX2s1TmJ4NEJzeVpXeHFaWXZSU3UyWWlGWDlITDZOUllkQkppWTBFWlRscGstUlphTVEwQlltNEdJeU9GcVB1WDFFMHFWeHBjTi1CUTJOUC1PT3J5aW9TS0twdjMzSkVhaVBMQmk3MUFmSHI2NHRweW9HQ2lWSmZDM3ZVZUlVZXY2Y3BNbXVvLVBvQ2xhVDRrM195TjZkcHVUcWJQY1AtbVBYbA&quest;oc&equals;5" target&equals;"&lowbar;blank">Hemogenyx conclui transferência de tecnologia para terapia CAR-T para CDMO<&sol;a>&nbsp&semi;&nbsp&semi;<font color&equals;"&num;6f6f6f">br&period;investing&period;com<&sol;font><br &sol;><a href&equals;"https&colon;&sol;&sol;news&period;google&period;com&sol;rss&sol;articles&sol;CBMiyAFBVV95cUxOSDBwZ1dpVnI4eXpiTF8yUlkzLUdISnBnQ0JQTlZaX2s1TmJ4NEJzeVpXeHFaWXZSU3UyWWlGWDlITDZOUllkQkppWTBFWlRscGstUlphTVEwQlltNEdJeU9GcVB1WDFFMHFWeHBjTi1CUTJOUC1PT3J5aW9TS0twdjMzSkVhaVBMQmk3MUFmSHI2NHRweW9HQ2lWSmZDM3ZVZUlVZXY2Y3BNbXVvLVBvQ2xhVDRrM195TjZkcHVUcWJQY1AtbVBYbA&quest;oc&equals;5" target&equals;"&lowbar;blank">Leia mais<&sol;a><&sol;p>&NewLine;